Promising Telitacicept Results Reported for Lupus, Sjögren's

Results of a phase 3 trial in Chinese patients with systemic lupus erythematosus showed a significantly greater response rate with telitacicept, compared with placebo.

Related Keywords

University Medical Center ,Texas ,United States ,Amsterdam ,Noord Holland ,Netherlands ,Dallas ,China ,Milan ,Lombardia ,Italy ,University Of Texas Southwestern Medical Center ,Chinese ,Roy Fleischmann ,Van Vollenhoven ,Bristol Myers Squibb ,Ronald Van Vollenhoven ,European Congress ,Pfizer ,Astrazeneca ,Vu University Medical Center ,Metroplex Clinical Research Center ,Amsterdam University Medical Center ,Systemic Lupus Erythematosus National Assessment ,Novartis ,Glaxosmithkline ,Medical Center ,Syndrome Disease Activity Index ,Texas Southwestern Medical Center ,Merck Sharp ,Systemic Lupus Erythematosus ,Sale ,Lupus ,Riga ,Eigg ,